Europe PMC requires Javascript to function effectively.
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please
turn on Javascript support in your web browser and reload this page.
PMC full text: | - Copyright/LicenseRequest permission to reuse
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
| |
Fig. 8
Prognostic performance of ERBB2 expression in subgroups of ccRCC patients. ERBB2 patients were classified into different subgroups according to race, T stage, N stage, M stage, histological grade, and pathological stage. (A–C) The Cox regression analysis results show the prognostic performance of ERBB2 expression levels in terms of (A) overall survival, (B) disease-specific survival, and (C) progression-free interval in different subgroups of ccRCC patients. The results are represented by the hazard ratio (HR). The bar represents the 95% confidence interval (CI) of the HR values, and the size of the circle represents the significance of the prognostic performance of ERBB2.
Images in this article
Click on the image to see a larger version.